Skip to content

Impact of Asthma Exacerbations

Impact of Asthma Exacerbations: A Qualitative Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04410120
Acronym
IMPAX
Enrollment
30
Registered
2020-06-01
Start date
2020-09-30
Completion date
2020-09-30
Last updated
2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma Attack

Brief summary

The purpose of the study is to gain a deeper understanding of the impact of asthma attacks on the lives of patients who experience them. This will help us to describe the true extent of the impact of asthma attacks on factors of importance to patients which have not previously been well described, including the psychological, social, financial and emotional burden of asthma attacks. Additionally, it is hoped that detailed questioning regarding features of asthma attacks from a patient perspective will improve our understanding of patient recognition of attacks, consistency of certain features of attacks and patient views regarding preventative strategies for attacks. Patient experiences of asthma attacks are poorly described in previous research. Hence this work is expected to provide useful insights into these experiences which will contribute to improvements in detecting, treating and preventing asthma attacks. The study will consist of a one-off interview lasting about 45 minutes with patients who have recently had asthma attacks. We plan to recruit patients for the study from an outpatient clinic for those who have had a recent attack or from a register of patients who have volunteered for future asthma research studies. The interviews will take place in person at the Respiratory Research Unit at the Nottingham City Hospital or over the telephone depending on patient preference.

Interventions

OTHERInterview

Semi-structured 45 minute interviews regarding impact of asthma attacks

Sponsors

University of Nottingham
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults with previous clinician diagnosis of asthma (16 years and above) * Recent (≤4 weeks) asthma attack for which patient received ≥3 days of systemic corticosteroid treatment

Exclusion criteria

* Anyone under the age of 16 years. * Anyone unable to speak or understand English.

Design outcomes

Primary

MeasureTime frameDescription
Thematic analysis of interview transcripts using framework approachOne off 45 minute interviewThematic analysis of interview transcripts using framework approach

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026